(Q48903856)

English

Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. (English)

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

author name string

D'Ambrogio G

1

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Fasciani A

2

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Monti M

3

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Cattani R

4

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Genazzani AR

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Artini PG

6

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

publication date

1 October 1999

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Gynecological Endocrinology

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

13

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

5

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

311-315

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167573

21 January 2018

Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167573

21 January 2018

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167573

21 January 2018

Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study.

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167573

21 January 2018

Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilization.

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167573

21 January 2018

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167573

21 January 2018

Identifiers

10.3109/09513599909167573

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

1 reference

Europe PubMed Central

16 February 2018

http://europepmc.org/abstract/MED/10599547

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48903856&oldid=953188763"